Company news
Recce Pharmaceuticals Ltd. news in 2019
Recce Pharmaceuticals Ltd.'s news releases, calls and decks from 2019, newest first.
Positive Data for RECCE 327 in MRSA Burns Wound Infection
November 26, 2019
Recce Completes Raising of $6.76 million
October 9, 2019
Key Family 2 Patent Granted in Japan for RECCE Antibiotics
September 20, 2019
Funding Update
September 11, 2019
Appendix 4E - Preliminary Final Report
August 30, 2019
FDA Positive Response for Recce Scaled Manufacture & Quality
August 26, 2019
Response to ASX Appendix 4C Query
August 16, 2019
Key Family 2 Patent Granted in Europe for RECCE Antibiotics
August 8, 2019
Opening R&D Address at World Antibiotic Resistance Congress
July 31, 2019
Appendix 4C and commentary
July 30, 2019
Appointment of Independent Chair and Additional Director
July 9, 2019
USA Patent Granted for Recces Antibiotics
March 13, 2019
Recce Successfully Raises $1.8 million via Placement
February 7, 2019